GENEVA--(BUSINESS WIRE)--Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of the UNITY ® Vitreoretinal Cataract System (VCS) and UNITY ® ...
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, announced results from time and motion studies demonstrating superior efficiency* with UNITY® ...
(RTTNews) - Eye care company Alcon Inc. (ALC) announced Monday that UNITY Vitreoretinal Cataract System or VCS and UNITY Cataract System or CS have received U.S. Food and Drug Administration's 510(k) ...
Basel, Switzerland, April 16, 2015-Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof ® IQ ReSTOR ® ...
Alcon Partners with Actress Cheryl Ladd to Share Her Cataract Journey, Renewed Vision and PanOptimist Story National multimedia campaign, “I’m a PanOptimist,” focuses on the renewed optimism of having ...
Alcon Centurion is a phacoemulsification unit for use in vitrectomy procedures. Your doctor may recommend laser cataract removal, which when combined with the Centurion offers the very latest ...
Novartis’ eye care division Alcon has set a goal to develop a digital platform for streamlining cataract surgery, in collaboration with Philips. The planned SMART Suite aims to link diagnostic and ...
Data on Alcon’s products across cataract, refractive, diagnostics and ocular health will be featured in presentations during the meeting Prospective analyses and studies demonstrate sustained ...
Basel, October 5, 2015-Alcon, the global leader in eye care and a division of Novartis, has received US Food and Drug Administration (FDA) approval for its AcrySof ® IQ Aspheric IOL with the UltraSert ...
“Alcon has a long legacy of advancing phaco and vitreoretinal technology for surgical ophthalmology. With UNITY VCS/CS, we are introducing more than a dozen innovations designed to transform surgical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results